Article
TFAP2E-DKK4 and chemoresistance in colorectal cancer.
The New England journal of medicine - 5 Jan 2012
Ebert Matthias P A, Tänzer Marc, Balluff Benjamin, Burgermeister Elke, Kretzschmar Antje Karen, Hughes David J, Tetzner Reimo, Lofton-Day Catherine, Rosenberg Robert, Reinacher-Schick Anke C, Schulmann Karsten, Tannapfel Andrea, Hofheinz Ralf, Röcken Christoph, Keller Gisela, Langer Rupert, Specht Katja, Porschen Rainer, Stöhlmacher-Williams Jan, Schuster Tibor, Ströbel Philipp, Schmid Roland M
Abstract excerpt
BACKGROUND: Chemotherapy for advanced colorectal cancer leads to improved survival; however, predictors of response to systemic treatment are not available. Genomic and epigenetic alterations of the gene encoding transcription factor AP-2 epsilon (TFAP2E) are common in human cancers. The gene encoding dickkopf homolog 4 protein (DKK4) is a potential downstream target of TFAP2E and has been implicated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
